Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-152
Closed -$12.3K 1083
2023
Q1
$12.3K Hold
152
﹤0.01% 960
2022
Q4
$11.4K Sell
152
-9
-6% -$641 ﹤0.01% 983
2022
Q3
$10K Sell
161
-6
-4% -$416 ﹤0.01% 1011
2022
Q2
$12K Buy
167
+43
+35% +$3.19K ﹤0.01% 902
2022
Q1
$10K Buy
124
+18
+17% +$1.29K ﹤0.01% 1094
2021
Q4
$8K Hold
106
﹤0.01% 1329
2021
Q3
$8K Sell
106
-10
-9% -$750 ﹤0.01% 1254
2021
Q2
$8K Buy
116
+32
+38% +$2.14K ﹤0.01% 1107
2021
Q1
$6K Buy
84
+46
+121% +$3.49K ﹤0.01% 1147
2020
Q4
$3K Hold
38
﹤0.01% 1094
2020
Q3
$3K Hold
38
﹤0.01% 951
2020
Q2
$2K Buy
+38
New +$1.86K ﹤0.01% 1063
2020
Q1
Sell
-5
Closed 1592
2019
Q4
$0 Hold
5
﹤0.01% 1598
2019
Q3
$0 Buy
+5
New +$246 ﹤0.01% 1546

Other funds holding HOLX

TCI Wealth Advisors's HOLX Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Hologic (HOLX) in Q2 2023, closing a stake of 152 shares — an estimated $12.3K sold.

TCI Wealth Advisors first reported a position in HOLX in Q3 2019 and held it in 14 quarters. The position peaked at $12.3K in Q1 2023. 713 funds tracked by Wall St. Rank hold HOLX as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Hologic position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 152 Hologic shares in Q2 2023, an estimated $12.3K.
  • TCI Wealth Advisors first reported a position in Hologic in Q3 2019 and held it in 14 quarters.
  • TCI Wealth Advisors's Hologic position peaked at $12.3K in Q1 2023.
  • 713 funds tracked by Wall St. Rank held Hologic as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.